We confirmed this result by immunostaining of 76 resected pancreatic cancer tissues, and moreover, showed that the expression level of FGFR2-IIIb is correlated with prognosis and the incidence of nodal involvement. This evidence concerns the gene FGFR2 and pancreatic neoplasm.